With stiff person syndrome, all the muscles of the body become stiff, in the form of attacks at first, then later constantly. Agoraphobia and extreme nervousness are also symptoms. If the disease is fully developed, the sufferer can neither walk nor stand and is then confined to a wheelchair.
Antibodies attack brain and spinal cord
The root of the syndrome is an immune disorder of the central nervous system: specific antibodies purposefully attack a protein in the brain and spinal cord. Normally, antibodies fend off harmful intruders, such as bacteria or viruses. However, they can also make the mistake of turning against the body itself, as happens with stiff person syndrome. Medical experts refer to this as an autoimmune disease.
With stiff person syndrome, the misguided antibodies attack the protein amphiphysin, which plays an important role in enabling the control points between nerve cells and also between nerves and muscles to work properly. According to the prevailing opinion in science, this protein is found inside the cells – and therefore should not actually be accessible to antibodies.
GABA deficiency leads to stiff person syndrome
However, the Würzburg researchers have provided clear evidence that the antibodies isolated from patients are able to reach their target molecule inside the cells and specifically bond with it. Via intermediate steps in the cell cycle they then cause a reduced release of the transmitter GABA, which inhibits the activity of the nerve cells. In the animal model, this leads to the typical symptoms of stiff person syndrome, such as muscle spasms, stiffness, and muscle cramps.
Publication in the journal Brain
Claudia Sommer, Christian Geis, and Klaus V. Toyka from the Department of Neurology present their new findings in the current issue of the renowned journal Brain. The publication came about in collaboration with Manfred Heckmann, head of the Würzburg Institute of Physiology. The German Research Foundation (DFG) funded the work in Collaborative Research Center 581 “Molecular Models for Diseases of the Nervous System”.
“We have proven using several techniques that the antibodies reach their goal,” says Claudia Sommer. The hidden paths the antibodies take to get there remain a mystery that the scientists are now looking to solve.
Prospects for therapy
If it proves possible to influence the activity of the antibodies with medication, for example, new possibilities in therapy might present themselves. This applies not only to stiff person syndrome, but also to other areas: “Antibodies also play a role in diseases that have other additional causes,” says Christian Geis. He cites, as an example, Neuromyelitis optica, a disease in which the antibody directs its destructive work against the spinal cord and optic nerves.
About stiff person syndrome
Stiff person syndrome is regarded as a rare disease. It affects an average of one person in every million. The Würzburg Department of Neurology has a total of ten patients in its care.
One way of relieving the symptoms of sufferers is with dialysis because this temporarily removes the harmful antibodies from the blood. The effect does not last though, since new antibodies continue to be produced by the B cells of the immune system. However, the B cells can also be attacked: with medication that inhibits their activity. “The method is relatively new and is working very well in a few patients,” comments Claudia Sommer.
Geis, C, Weishaupt, A., Hallermann, S., Grünewald, B., Wessig, C., Wultsch, T., Reif, A., Byts, N., Beck, M., Jablonka, S., Boettger, M., Üçeyler, N., Fouquet, W., Gerlach, M., Meinck, H-M., Sirén, A-L., Sigrist, S.J., Toyka, K.V., Heckmann, M., Sommer, C. (2010). Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain 2010; doi: 10.1093/brain/awq253
Dr. Christian Geis, Department of Neurology at the University of Würzburg, phone +49 (0)931 201-24617, email@example.com
Prof. Dr. Claudia Sommer, Department of Neurology at the University of Würzburg, phone +49 (0)931 201-23763, firstname.lastname@example.org
Robert Emmerich | idw
Climate Impact Research in Hannover: Small Plants against Large Waves
17.08.2018 | Leibniz Universität Hannover
First transcription atlas of all wheat genes expands prospects for research and cultivation
17.08.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung
New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference
Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
17.08.2018 | Event News
08.08.2018 | Event News
27.07.2018 | Event News
17.08.2018 | Physics and Astronomy
17.08.2018 | Information Technology
17.08.2018 | Life Sciences